Overall rank by patents
#27,674
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Transcend ranks #27,674 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R27674 · US Corporation #27,674 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Top Glove International Sdn. Bhd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Transcend Medical · this assignee
24 score
3D Lighting… · lowest
7 score
What this shows Transcend's Innovation Score is 24.4/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Transcend Medical, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (6 grants) versus a trough of 4 in 2016. By volume, Transcend sits between Top Glove International Sdn. Bhd. and Travelers Club Luggage, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Top Glove International Sdn. Bhd.
10 patents
Total Piping Solutions, Inc.
10 patents
Trait Biosciences, Inc.
10 patents
TransRobotics, Inc.
10 patents
Transdev Group Innovation
10 patents
Transhield, Inc.
10 patents
Travel Tags, Inc.
10 patents
Travelers Club Luggage, Inc.
10 patents
Transcend Medical, Inc.
10 patents
What this shows Transcend holds 10 patents at rank #27,678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,678 in granted patent volume.
Other assignees with the most granted patents in Transcend's primary technology class.
Transcend's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 15th percentile higher than 15% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 60.0% |
| 2016 | 4 | 40.0% |
Top 6 of 6 technology areas
Overall rank by patents
#27,674
of 49,997 tracked assignees
24.4 out of 100
What to do with this data
Transcend Medical, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.